Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Diagnosing Vascular Dementia: How Doctors Identify Blood Vessel Damage
Could Existing Drugs like Viagra Treat Alzheimer’s Disease?
How ApoE4 Increases Alzheimer’s Risk: What Blood Proteins Are Revealing
Frontotemporal Dementia Treatments: What Helps Now and What’s Coming Next
GLP-1 Semaglutide Fails to Slow Alzheimer’s Despite Biomarker Changes
The Challenge of Diagnosing Frontotemporal Dementia
Shingles Vaccine Linked to Lower Dementia Risk — What to Know
Vascular Dementia 101: Causes, Risk Factors, Symptoms
POINTER: Lifestyle Shifts Improve Sleep and Brain Blood Vessels
FTD 101: Your Being Patient Primer on Frontotemporal Dementia
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s Trial
Digital Twins: The Sci-Fi Innovation Behind New Personalized Disease Treatments
Potential First: Pill for Lewy Body Dementia Heads to a Phase 3 Trial
FDA Clears Blood Test to Help Doctors Rule Out Alzheimer’s
When Insurance Refused to Cover His Alzheimer’s Treatment, He Found Another Way
Previous
4
5
6
Next
Page load link
Go to Top